ResearcherWuhan UniversityNo recent work listed

Qian Zhu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1203-3278, 0000-0003-0969-9404; OpenAlex author ID A5100616512. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2022: 2 papers

Papers 2

A Novel Immune-Related Prognostic Signature Predicting Survival in Patients with Pancreatic Adenocarcinoma. Co-author DOI 10.1155/2022/8909631 ↗
Restored CD8+PD-1+ T Cells Facilitate the Response to Anti-PD-1 for Patients With Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/fonc.2022.837560 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yufeng Yuan · 2 shared papers, 2022 · strength 0.34
- Paper A Novel Immune-Related Prognostic Signature Predicting Survival in Patients with Pancreatic Adenocarcinoma. DOI 10.1155/2022/8909631 ↗
- Paper Restored CD8+PD-1+ T Cells Facilitate the Response to Anti-PD-1 for Patients With Pancreatic Ductal Adenocarcinoma. DOI 10.3389/fonc.2022.837560 ↗
Xiao Zhang · 1 shared paper, 2022 · strength 0.20
- Paper A Novel Immune-Related Prognostic Signature Predicting Survival in Patients with Pancreatic Adenocarcinoma. DOI 10.1155/2022/8909631 ↗
Guoliang Qiao · 1 shared paper, 2022 · strength 0.14
- Paper Restored CD8+PD-1+ T Cells Facilitate the Response to Anti-PD-1 for Patients With Pancreatic Ductal Adenocarcinoma. DOI 10.3389/fonc.2022.837560 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.